Case Report
Two Years of Gynecomastia Caused by Leydig Cell Tumor
Table 1
Laboratory results before and after surgery. After surgery, secondary hypogonadotropic hypogonadism resolved. (mo: month/months, w: week, FSH: follicle-stimulating hormone, LH: luteinizing hormone, SHBG: sex hormone-binding globulin, DHEA-S: dehydroepiandrosterone sulfate, AFP: alpha-fetoprotein, β-hCG: beta-human chorionic gonadotropin, and LDH: lactate dehydrogenase).
| parameter (normal value) | time before surgery | time after surgery | 10 mo | 3 mo | 1 w | 1 mo | 4 mo | 10 mo |
| FSH (1.3 – 19.3 mIU/ml) | | | - | 3.0 | 2.8 | 2.3 | LH (1.2 – 8.6 mIU/ml) | 2.8 | 1.6 | - | 7.59 | 8.1 | 5.28 | Prolactin (86 – 300 μIU/ml) | | - | - | 260 | 268 | 170 | Estradiol (< 47 pg/ml) | | 26.2 | - | - | 16.6 | 25.7 | Testosterone (1.75 – 7.81 μg/l) | | | - | 4.08 | 3.65 | 3.71 | SHBG (13.2 – 89.5 nmol/l) | 21.7 | 17.9 | - | - | - | - | DHEA-S (1200 – 5200 μg/l) | 2590 | 2680 | - | - | - | - | ΑFP (< 10 ng/ml) | 1.8 | 2.5 | 2.5 | - | 2.0 | 2.0 | β-hCG (< 2.71 U/l) | < 0.5 | < 0.5 | < 0.1 | - | < 0.1 | < 0.1 | LDH (0-262 U/l) | - | - | 231 | - | 184 | 245 |
|
|